The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) Shares outstanding
The Cooper Companies, Inc.'s shares outstanding at the end of fiscal 2025 was $200.0M, unchanged from fiscal 2024. At the end of the quarter to 31 July 2026 it was $193.4M. Over the past ten years it has ranged from $196.0M (fiscal 2016) to $200.4M (fiscal 2024); the current reading is higher than 91% of that period. The Cooper Companies, Inc. ranks 10th of 50 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $200.0M | (0.20%) |
| FY2024 | $200.4M | 0.55% |
| FY2023 | $199.3M | 0.25% |
| FY2022 | $198.8M | (0.20%) |
| FY2021 | $199.2M | 0.40% |
| FY2020 | $198.4M | (0.80%) |
| FY2019 | $200.0M | 0.60% |
| FY2018 | $198.8M | 0.20% |
| FY2017 | $198.4M | 1.22% |
| FY2016 | $196.0M | (0.41%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jul 2026 | $193.4M | (0.82%) |
| Apr 2026 | $195.0M | (0.86%) |
| Jan 2026 | $196.7M | (1.65%) |
| Oct 2025 | $200.0M | 0.00% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $677.2M |
| BAX Baxter International Inc. compare | $518.0M |
| BLCO Bausch + Lomb Corporation compare | $357.1M |
| COO The Cooper Companies, Inc. | $193.4M |
| SOLV Solventum Corporation compare | $173.3M |
| ALGN Align Technology, Inc. compare | $71.5M |
| ATR AptarGroup, Inc. compare | $64.2M |
| RGEN Repligen Corporation compare | $56.6M |
| TFX Teleflex Incorporated compare | $43.7M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement